The best way for those interested in finding the prescribed drug is to speak to their own clinicians or health insurance providers, reports Very Well Health. When the shortages were initially announced, small pharmacies felt the impact in a strong way.Ī National Community Pharmacists Association survey of about 8,000 pharmacy owners and managers found that more than 6 in 10 small pharmacies reported having difficulty obtaining Adderall. The manufacturer SpecGX, which operates under the umbrella of Mallinckrodt, also anticipates supply constraints of its 20 mg and 30 mg Adderall products.Ī spokesperson for Mallinckrodt declined to comment to Newsweek. The FDA said it continues to work closely with Teva to monitor the drug's availability and assist in any resolutions regarding supply.
Newsweek reached out to Teva for comment. While Teva has an array of Adderall medications available, the database lists numerous items on backorder that were supposed to be replenished between October and December of this year. Aleksandar Karanov/Getty Benjamin Vincent Kasapoglu via Wikimedia Commons The FDA said Wednesday that additional supply shortages are expected for an additional month or two. The FDA said it was "in frequent communication with all manufacturers of amphetamine mixed salts," including Teva-which, according to NPR, sells the most Adderall annually in the U.S.Ī pharmacist looks at shelves with an inset of Adderall. The drug is prescribed to individuals for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. On October 12 the FDA announced the shortage of immediate-release formulation of amphetamine mixed salts, more commonly known as Adderall, due to supply chain shortages and manufacturing delays. "While the agency does not manufacture drugs and cannot require a pharmaceutical company to make a drug, make more of a drug, or change the distribution of a drug, the public should rest assured the FDA is working closely with numerous manufacturers and others in the supply chain to understand, mitigate and prevent or reduce the impact of intermittent or reduced availability of certain products," the statement continued. The FDA told Newsweek in a statement that it "recognizes the potential impact that reduced availability of certain products may have on healthcare providers and patients." Rhodes, which previously had more backorders, has all Adderall-related products available except 5 mg bottles of 100 tablets.
The FDA database currently lists seven manufacturers with available Adderall products, and they are: Alvogen, Lannett Company, Inc., Rhodes Pharmaceuticals, Sandoz, SpecGX LLC, Sunrise Pharmaceutical, Inc., and Teva Pharmaceuticals.Įpic Pharma LLC is completely back-ordered and has no medication available. In correspondence on Wednesday with Newsweek, an FDA spokesperson said they expect additional supply shortages of Adderall to continue another 30 to 60 days, "in which time the overall market demand should be met with currently available supply." The Food and Drug Administration ( FDA) is anticipating continued supply delays that have led to a national shortage of Adderall.
0 kommentar(er)
